Unknown

Dataset Information

0

Lipoxins reduce obesity-induced adipose tissue inflammation in 3D-cultured human adipocytes and explant cultures.


ABSTRACT: Adipose tissue inflammation drives obesity-related cardiometabolic diseases. Enhancing endogenous resolution mechanisms through administration of lipoxin A4, a specialized pro-resolving lipid mediator, was shown to reduce adipose inflammation and subsequently protects against obesity-induced systemic disease in mice. Here, we demonstrate that lipoxins reduce inflammation in 3D-cultured human adipocytes and adipose tissue explants from obese patients. Approximately 50% of patients responded particularly well to lipoxins by reducing inflammatory cytokines and promoting an anti-inflammatory M2 macrophage phenotype. Responding patients were characterized by elevated systemic levels of C-reactive protein, which causes inflammation in cultured human adipocytes. Responders appeared more prone to producing anti-inflammatory oxylipins and displayed elevated prostaglandin D2 levels, which has been interlinked with transcription of lipoxin-generating enzymes. Using explant cultures, this study provides the first proof-of-concept evidence supporting the therapeutic potential of lipoxins in reducing human adipose tissue inflammation. Our data further indicate that lipoxin treatment may require a tailored personalized-medicine approach.

SUBMITTER: Sotak M 

PROVIDER: S-EPMC9249816 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6266132 | biostudies-literature
| S-EPMC3519463 | biostudies-literature
| S-EPMC4219530 | biostudies-literature
| S-EPMC2798678 | biostudies-literature
| S-EPMC7331453 | biostudies-literature
| S-EPMC4160987 | biostudies-literature
| S-EPMC4897685 | biostudies-other
| S-EPMC3767362 | biostudies-literature
| S-EPMC9135524 | biostudies-literature
| S-EPMC6510792 | biostudies-literature